The company's plants have implemented a quality control system in accordance with international GMP quality standards.

  • GMP

    rules of production practice

  • 3

    modern pharmaceutical plants

  • ISO 9001

    international quality standard

Avexima has introduced dozens of medicines to the market, which, due to their effectiveness and accessibility, have been highly appreciated by both specialists and consumers, identifying themchoice.

We are investing heavily in equipment modernization and expansion of production capabilities, taking into account current trends and trends in the pharmaceutical market.

Production
facilities

Kemerovo region, Anzhero-Sudzhensk

Avexima Siberia LLC

One of the most modern pharmaceutical plants in Siberia.

detail

Sverdlovsk region, Irbit

JSC "Irbit Chemical Pharmaceutical Plant"

The production is equipped with the latest technology, standardized according to GMP standards.

detail

Moscow

Immafarma JSC

Production of high-demand immune drugs "Gepon"
and "Immunomax", the search for solutions in the field of immunology is underway.

detail

Production
potential

In the context of the urgency of strengthening Russia's drug safety, Avexima has become the main initiator and investor in the implementation of an investment project to create a large pharmaceutical cluster in the Esipovo Industrial Park in the Moscow Region. The project to create a modern pharmaceutical industrial and logistics complex is the real embodiment of the company's development program within the framework of the state program "Pharma 2030".

Investment project

FPLK Esipovo

An investment project in the Esipovo Industrial Park in the Solnechnogorsk district of the Moscow Region

detail

An advanced center for scientific research and production of modern drugs will be created on the basis of FPLK Esipovo, and a modern logistics center for drug distribution will be built in partnership with pharmaceutical distributor FC Grand Capital.